Decoding India’s Pharmaceutical Neutral Code for Exported Drugs
In the Indian pharmaceutical industry, export products are marked with a “neutral code” or “special code” to keep the manufacturer’s identity confidential, complying with international regulatory requirements. This system supports India’s robust position in the global market by ensuring regulatory compliance and maintaining confidentiality. Manufacturers must apply to the CDSCO with necessary documentation to obtain a neutral code, facilitating the export process. When multiple firms share the same neutral code, it indicates they use a common contract manufacturing facility, promoting streamlined regulatory compliance and business confidentiality. Products with a neutral code are intended exclusively for export, ensuring they do not enter the domestic market.